@CanAkerman

Postdoctoral Fellow @johnshopkins, Rothstein lab, studying neurodegeneration. Previously: McGill, ETH Zurich, Penn State

Joined May 2021
Suleyman Can Akerman retweeted
The sphingosine-1-phosphate receptor functional antagonist fingolimod exacerbates neuroinflammation and tau pathology in a mouse model of tauopathy biorxiv.org/content/10.64898…
1
10
33
2,216
Great to be part of #ALSNexus26 last week! I presented our work on modulating extracellular vesicles to inhibit dipeptide repeat propagation in C9-ALS, both in the Emerging Science session and as a poster. Great discussions across the ALS community. #ALS
1
8
246
NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a Drosophila tauopathy model sciencedirect.com/science/ar…
1
66
Intersting preprint: blocking VPS4a could keep TDP-43 out of exosomes without stopping exosome production. That would suggest that one might be able to block the neuron-to-neuron spread of pathology without shutting down normal vesicle trafficking. biorxiv.org/content/10.64898…
1
5
13
1,293
Suleyman Can Akerman retweeted
Injury-induced tau pathology promotes aggressive behavior in Drosophila without neurodegeneration | PNAS pnas.org/doi/10.1073/pnas.26…
1
7
21
2,057